Influenza Diagnostics Market include deep analysis of this key Thermo Fisher Scientific (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Quidel Corporation (U.S.), Becton, Dickinson and Company (U.S.), DiaSorin (Italy), SA Scientific (U.S.), and Luminex Corporation (U.S.). players
The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0million in 2016, influenza diagnostics market at a CAGR of 8.6% from 2016 to 2021.
The report provides insights on the following pointers: Get sample copy@ www.reportsnreports.com/contacts/r….aspx?name=883581
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, the European region is expected to account for the largest share of the market due to the rapidly increasing prevalence of influenza and rise in aging population in Europe.
Inquire For Complete Report Copy of Influenza diagnostics Market by Product (Automated Systems (Milking Parlours, Meters, Sensors, Reproductive & Health, Cattle Management), Software (On-premise, Cloud-based)), Application (Feeding, Breeding), End user (Large Farms) - Global Forecast to 2022 at www.reportsnreports.com/contacts/i….aspx?name=883581
On the basis of test type, the market is segmented into traditional and molecular diagnostic tests.
The traditional diagnostic tests segment is further categorized into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. In 2016, the RIDT segment is expected to account for the largest share of the traditional tests market owing to factors such as its user-friendliness, rapid generation of results, and easy interpretability.
The molecular diagnostic tests segment is further divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), and simple amplification-based assays (SAMBA).In 2016, the RT-PCR segment is expected to hold the largest share of the molecular diagnostic tests market due to its ability to detect and distinguish between influenza A and B viruses with high specificity.
On the basis of end user, the influenza diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, and other end users (point-of-care testing, home health agencies, and nursing homes).
The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for rapid and effective disease diagnosis and treatment are the key factors driving the growth of the global influenza diagnostics market.
Target Audience for this Report:
- Academic Institutes
- Diagnostic Solution Providers
- Research Institutes
- Reference Laboratories
- Diagnostic Suppliers
- Home Health Agencies
- Market Research and Consulting Firms
“Influenza diagnostics Market” spread across 127 pages, profiling 10 companies and supported with 91 tables and 33 figures is Direct Access this Report @ www.reportsnreports.com/purchase.aspx?name=883581
major players in the influenza diagnostics market are Thermo Fisher Scientific (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Quidel Corporation (U.S.), Becton, Dickinson and Company (U.S.), DiaSorin (Italy), SA Scientific (U.S.), and Luminex Corporation (U.S.).
Key Point from Table of Content
6 Influenza Diagnostics Market, By Test Type
6.2 Traditional Diagnostic Tests
6.2.1 Rapid Influenza Detection Tests (RIDT)
6.2.2 Viral Culture
6.2.3 Direct Fluorescent Antibody (DFA) Tests
6.2.4 Serological Assays
6.3 Molecular Diagnostic Tests
6.3.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
6.3.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
6.3.4 Simple Amplification-Based Assays (SAMBA)
6.3.5 Other Molecular Diagnostic Tests
7 Influenza Diagnostics Market, By End User
7.2 Hospitals/Clinical Laboratories
7.3 Reference Laboratories
7.4 Other End Users
Inquire For This Influenza diagnostics Market@ www.reportsnreports.com/contacts/d….aspx?name=883581